Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.360
+0.150 (6.79%)
At close: Jun 26, 2026, 4:00 PM EDT
2.300
-0.060 (-2.54%)
After-hours: Jun 26, 2026, 7:55 PM EDT
Acumen Pharmaceuticals Employees
Acumen Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
61
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,856,984
Market Cap
170.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Innate Pharma | 164 |
| LENZ Therapeutics | 152 |
| Caribou Biosciences | 97 |
| Tenaya Therapeutics | 70 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
| Corbus Pharmaceuticals Holdings | 36 |
ABOS News
- 10 days ago - JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform - Business Wire
- 11 days ago - Acumen nominates two development candidates in EBD program - TheFly
- 11 days ago - Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer's Disease - GlobeNewsWire
- 6 weeks ago - Acumen Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Acumen Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Acumen Pharmaceuticals Earnings release: Q1 2026 - Filings
- 6 weeks ago - Acumen Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire